You are here
- Home
- Therapy Areas
Gastrointestinal
The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Nexium capsules Clinical Experience Investigation
- collapse Drug utilization and safety events among children using esomeprazole, other proton pump inhibitors or H2-receptor antagonists
- collapse Nexium capsules Hp Specific Clinical Experience Investigation
- collapse European Real Life Study on NSAIDs Treated Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS): Assessment of Pain Relieve, Gastrointestinal (GI) Symptoms, Adherence and Health Resource Consumption
- collapse Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding
-
expand
A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease (CD) in Japan
- Study Id
- D9423C00001
- Disease
- Crohn's disease
- Drug Name
- Entocort capsules
- Study Name
- D9423C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
- collapse National Survey on GERD Patients (Adults and Children)
- collapse Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
- collapse A Phase I, Open-label, Randomized, Single-center, 2-way Crossover Bioequivalence Study Comparing a Pellets Based Sachet Formulation of D961H 20 mg and a Commercial HPMC Capsule of D961H 20 mg After Repeated Oral Administration in Japanese Healthy Male Subjects.
- collapse Observational Study to Evaluate Helicobacter Pylori Susceptibility to Clarithromycin and to Estimate Eradication and Healing Rates of Duodenal Ulcer Routine Eradication Therapy at the End of Treatment and 52 Weeks From the Therapy Start
